10-Q: PCMC Reports Q3 2025 Loss, Pursues Healthcare Merger

Public Company Management Corporation reported increased losses in Q3 2025 and continues to seek a business combination, with preliminary discussions underway for a merger with Physicians Capital Management Corporation.

Summary

• Reported a net loss of $(25,864) for the three months ended June 30, 2025, an increase from $(13,945) in the prior year period.
• Nine-month net loss increased to $(73,356) for the period ended June 30, 2025, compared to $(44,586) for the same period in 2024.
• Cash balance increased to $273,978 as of June 30, 2025, from $100,035 at September 30, 2024.
• Total liabilities grew to $919,678 as of June 30, 2025, from $672,379 at September 30, 2024.
• Accumulated deficit reached $(5,699,716) as of June 30, 2025.
• The company is a shell company with no current business operations or revenues, actively seeking a business combination.
• Preliminary discussions are ongoing for a potential merger with Physicians Capital Management Corporation, a healthcare facilities acquisition and development company.

Sentiment

Score: 3

Explanation: The company is a non-operating shell with increasing losses and a significant accumulated deficit, raising substantial doubt about its going concern ability. While it has increased cash and is actively pursuing a business combination, its financial health is precarious and entirely dependent on external funding, making it a high-risk investment.

Positives

• Cash balance increased significantly from $100,035 at September 30, 2024, to $273,978 as of June 30, 2025.
• Management concluded that internal control over financial reporting was effective.
• Actively pursuing a business combination, with specific discussions noted with Physicians Capital Management Corporation, indicating a potential path to becoming an operating entity.

Negatives

• No revenues generated during the reported periods (three and nine months ended June 30, 2025 and 2024).
• Increased net losses for both the three-month (from $(13,945) to $(25,864)) and nine-month (from $(44,586) to $(73,356)) periods ended June 30, 2025.
• Accumulated deficit continues to grow, reaching $(5,699,716) as of June 30, 2025.
• Operating expenses increased for the three-month period ended June 30, 2025, compared to the prior year.
• Negative cash flows from operating activities, worsening from $(33,021) to $(101,057) for the nine months ended June 30, 2025.
• Significant working capital deficit of $(645,700) as of June 30, 2025.
• Substantial doubt about the ability to continue as a going concern, as expressed by independent accountants.
• Increased short-term payables and related party debt.

Risks

• Inability to raise sufficient capital or complete a business combination to achieve profitability.
• Dependence on interim funding from Repository Services LLC or Specialty Capital Lenders LLC, with no assurance of continued availability on acceptable terms.
• Potential significant dilution of existing shareholders' equity interest if a business combination involves issuing restricted shares of capital stock.
• Risk of a change in control and potential resignation or removal of current officer and director if a substantial number of shares are issued for a business combination.
• Adverse effect on the prevailing market price for common stock due to issuance of additional shares.
• Risk of default and foreclosure on assets if debt securities are issued and operating revenues are insufficient to cover obligations.
• Inability to obtain additional financing if debt securities contain restrictive covenants.
• Uncertainty regarding the ability to accurately predict or control future events that may cause actual results to differ materially from expectations.
• Additional uncertainties not currently known or deemed immaterial could adversely affect the business, financial condition, and/or plan of operation.

Future Outlook

The company's primary future outlook is to complete a business combination with an operating company, potentially involving the issuance of capital stock or debt. It anticipates incurring ongoing costs for SEC reporting, franchise fees, and professional services, which it expects to cover through existing cash and further borrowings from Repository Services LLC and/or Specialty Capital Lenders LLC. The maturity date for the $350,000 promissory note has been extended to December 31, 2026.

Management Comments

• Our operations are dependent on our ability to raise sufficient capital or complete business combination as a result of which we become profitable.
• We are dependent upon interim funding to be provided by Repository Services LLC or Specialty Capital Lenders LLC to pay professional fees and expenses.
• Repository Services LLC has agreed to provide funding as may be required to pay for accounting fees and other administrative expenses of the Company until the Company enters into a business combination.
• We would be unable to continue as a going concern without interim financing provided by Repository Services LLC.
• We currently plan to satisfy our cash requirements for the next twelve months through our cash on hand and borrowings from Repository Services LLC or Specialty Capital Lenders LLC or entities or individuals affiliated with either and believes it can satisfy its cash requirements so long as the Company are able to obtain financing from these parties.
• Management has concluded that our internal control over financial reporting was effective for the reported then quarter ended.

Industry Context

The company operates as a shell entity, a common structure for companies seeking to acquire an operating business to become a publicly traded entity. Its current discussions with Physicians Capital Management Corporation indicate a strategic pivot towards the healthcare facilities sector, aligning with broader trends of consolidation and investment in specialized real estate assets within the healthcare industry. This strategy aims to transform the company from a non-operational shell into an active business, a typical path for such entities to gain market relevance and generate revenue.

Comparison to Industry Standards

• As a shell company with no current operations or revenue, direct comparison to revenue-generating industry peers is not applicable.
• The company's financial performance, characterized by consistent losses and an accumulated deficit, is typical for a non-operating shell company that incurs administrative and compliance costs without corresponding revenue.
• The reliance on related-party funding and the 'going concern' warning are common for shell companies that have not yet completed a business combination.
• The pursuit of a business combination with an operating company, specifically in healthcare facilities, aligns with the standard strategy for shell companies to acquire an active business and transition into an operational entity.

Corporate Governance

Related Party Transactions

• A $350,000 promissory note owed to Specialty Capital Lenders LLC, a related party, with accrued interest of $91,904 as of June 30, 2025. This note was originally issued to Stephen Brock (former CEO) and assigned to Specialty Capital Lenders LLC.
• Owed $4,799 to related parties for funds advanced for general and administrative expenses as of June 30, 2025.
• Repository Services LLC has agreed to provide interim funding for accounting and administrative expenses, indicating a significant financial relationship.

Stakeholder Impact

• Shareholders: Potential significant dilution of equity interest if a business combination involves the issuance of a substantial number of new shares. The prevailing market price for common stock may be adversely affected. Investment is high risk due to going concern issues and reliance on external funding.
• Creditors (Repository Services LLC, Specialty Capital Lenders LLC): The company is heavily reliant on these related parties for ongoing funding, indicating their critical role in the company's continued existence. Their ability to recover loans is tied to the company's success in a business combination.
• Management/Employees: The current officer and director (Quynh Hoa T. Tran) may face resignation or removal if a business combination results in a change of control.

Next Steps

• Continue to seek a business combination with an operating company.
• Potentially issue restricted shares of capital stock or debt to effect a business combination.
• File a Current Report on Form 8-K if discussions with Physicians Capital Management Corporation result in a definitive agreement or material event.
• Continue to raise funds through debt and equity financing to cover expenditures.
• Satisfy cash requirements for the next twelve months through cash on hand and borrowings from Repository Services LLC or Specialty Capital Lenders LLC.
• Incur ongoing costs related to SEC reporting, franchise fees, transfer agent fees, registered agent fees, legal fees, and accounting fees.

Key Dates

Recommendation

The company is a non-operating shell with no revenue and increasing net losses, leading to a substantial accumulated deficit and a significant working capital deficit. Its independent accountants have expressed substantial doubt about its ability to continue as a going concern, as it is entirely dependent on interim funding from related parties. While it is actively seeking a business combination, the success of such an endeavor is highly uncertain, and any potential merger could lead to significant dilution for existing shareholders and a change in control. The financial position is extremely precarious, making it a high-risk investment with a strong likelihood of further value erosion.

Keywords

Shell Company, Business Combination, Merger, Healthcare Facilities, Financial Loss, Going Concern, SEC Filing, 10-Q, Corporate Governance, Public Company Management Corporation, PCMC, Physicians Capital Management Corporation